SciSparc Ltd. (SPRC)
NASDAQ: SPRC · Real-Time Price · USD
4.550
+0.170 (3.88%)
At close: May 19, 2026, 4:00 PM EDT
4.600
+0.050 (1.10%)
After-hours: May 19, 2026, 5:48 PM EDT
SciSparc Revenue
In the year 2025, SciSparc had annual revenue of $856.00K, down -34.46%. SciSparc had revenue of $856.00K in the quarter ending December 31, 2025, a decrease of -34.46%.
Revenue (ttm)
$856.00K
Revenue Growth
-34.46%
P/S Ratio
3.01
Revenue / Employee
$428,000
Employees
2
Market Cap
2.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 856.00K | -450.00K | -34.46% |
| Dec 31, 2024 | 1.31M | -1.57M | -54.64% |
| Dec 31, 2023 | 2.88M | 1.53M | 113.73% |
| Dec 31, 2022 | 1.35M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ensysce Biosciences | 4.71M |
| Scinai Immunotherapeutics | 1.31M |
| Biodexa Pharmaceuticals | 104.90K |
| Azitra | 7.50K |
| Virax Biolabs Group | 2.99K |
SPRC News
- 19 days ago - Neurothera Labs Announces Continuance into Ontario - TheNewswire
- 26 days ago - Neurothera Labs Engages bullVestor for Investor Relations Activities - TheNewswire
- 2 months ago - SciSparc discloses patent application for depression yherapy - TheFly
- 2 months ago - SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy - GlobeNewsWire
- 2 months ago - SciSparc’s Neurothera Labs announces publication of international patent - TheFly
- 2 months ago - SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease - GlobeNewsWire
- 2 months ago - SciSparc says Neurothera Labs agrees to acquire majority stake in CliniQuantum - TheFly
- 2 months ago - SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails - GlobeNewsWire